316 related articles for article (PubMed ID: 8799558)
1. Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: possible lack of relationship to immunosuppressive activity.
Lo Russo A; Passaquin AC; André P; Skutella M; Rüegg UT
Br J Pharmacol; 1996 Jun; 118(4):885-92. PubMed ID: 8799558
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of enhanced vasoconstrictor hormone action in vascular smooth muscle cells by cyclosporin A.
Lo Russo A; Passaquin AC; Rüegg UT
Br J Pharmacol; 1997 May; 121(2):248-52. PubMed ID: 9154334
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin A potentiates receptor-activated [Ca2+]c increase.
Lo Russo A; Passaquin AC; Cox C; Rüegg UT
J Recept Signal Transduct Res; 1997; 17(1-3):149-61. PubMed ID: 9029487
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine A up-regulates angiotensin II receptors and calcium responses in human vascular smooth muscle cells.
Avdonin PV; Cottet-Maire F; Afanasjeva GV; Loktionova SA; Lhote P; Ruegg UT
Kidney Int; 1999 Jun; 55(6):2407-14. PubMed ID: 10354289
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of cyclosporin potentiation of vasoconstriction of the isolated rat mesenteric arterial bed: role of extracellular calcium.
Rego A; Vargas R; Suarez KR; Foegh ML; Ramwell PW
J Pharmacol Exp Ther; 1990 Sep; 254(3):799-808. PubMed ID: 2395112
[TBL] [Abstract][Full Text] [Related]
6. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin.
Bell A; Wernli B; Franklin RM
Biochem Pharmacol; 1994 Aug; 48(3):495-503. PubMed ID: 7520696
[TBL] [Abstract][Full Text] [Related]
7. Sympathetic neural mechanisms of cyclosporine-induced hypertension.
Sander M; Lyson T; Thomas GD; Victor RG
Am J Hypertens; 1996 Nov; 9(11):121S-138S. PubMed ID: 8931845
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of calcineurin by cyclosporin A-cyclophilin requires calcineurin B.
Haddy A; Swanson SK; Born TL; Rusnak F
FEBS Lett; 1992 Dec; 314(1):37-40. PubMed ID: 1333415
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of vasopressin V1A receptor mRNA and protein in vascular smooth muscle cells following cyclosporin A treatment.
Cottet-Maire F; Avdonin PV; Roulet E; Buetler TM; Mermod N; Ruegg UT
Br J Pharmacol; 2001 Feb; 132(4):909-17. PubMed ID: 11181432
[TBL] [Abstract][Full Text] [Related]
10. Calcineurin is essential in cyclosporin A- and FK506-sensitive yeast strains.
Breuder T; Hemenway CS; Movva NR; Cardenas ME; Heitman J
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5372-6. PubMed ID: 7515500
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive activity of [MeBm2t]1-, D-diaminobutyryl-8-, and D-diaminopropyl-8-cyclosporin analogues correlates with inhibition of calcineurin phosphatase activity.
Nelson PA; Akselband Y; Kawamura A; Su M; Tung RD; Rich DH; Kishore V; Rosborough SL; DeCenzo MT; Livingston DJ
J Immunol; 1993 Mar; 150(6):2139-47. PubMed ID: 7680683
[TBL] [Abstract][Full Text] [Related]
12. Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin.
Ryffel B; Weber E; Mihatsch MJ
Exp Nephrol; 1994; 2(6):324-33. PubMed ID: 7532090
[TBL] [Abstract][Full Text] [Related]
13. The mechanisms of action of cyclosporin A : implications for its side effects.
Takahashi N
J Toxicol Sci; 1995 Sep; 20(4):480-2. PubMed ID: 8531247
[No Abstract] [Full Text] [Related]
14. Cyclosporin-mediated inhibition of bovine calcineurin by cyclophilins A and B.
Swanson SK; Born T; Zydowsky LD; Cho H; Chang HY; Walsh CT; Rusnak F
Proc Natl Acad Sci U S A; 1992 May; 89(9):3741-5. PubMed ID: 1315036
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine A impairs norepinephrine-induced vascular contractility.
Bergler T; Resch M; Reinhold SW; Birner C; Jungbauer CG; Griese DP; Schmid P; Banas B; Endemann D
Kidney Blood Press Res; 2012; 35(6):655-62. PubMed ID: 23095665
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporin A, FK506 and rapamycin: more than just immunosuppression.
Kunz J; Hall MN
Trends Biochem Sci; 1993 Sep; 18(9):334-8. PubMed ID: 7694398
[TBL] [Abstract][Full Text] [Related]
17. Cyclophilin residues that affect noncompetitive inhibition of the protein serine phosphatase activity of calcineurin by the cyclophilin.cyclosporin A complex.
Etzkorn FA; Chang ZY; Stolz LA; Walsh CT
Biochemistry; 1994 Mar; 33(9):2380-8. PubMed ID: 8117697
[TBL] [Abstract][Full Text] [Related]
18. Cellular mechanisms of cyclosporine A-associated side-effects: role of endothelin.
Meyer-Lehnert H; Bokemeyer D; Friedrichs U; Bäcker A; Kramer HJ
Kidney Int Suppl; 1997 Oct; 61():S27-31. PubMed ID: 9328959
[TBL] [Abstract][Full Text] [Related]
19. Potent vasoconstrictor actions of cyclopiazonic acid and thapsigargin on femoral arteries from spontaneously hypertensive rats.
Nomura Y; Asano M; Ito K; Uyama Y; Imaizumi Y; Watanabe M
Br J Pharmacol; 1997 Jan; 120(1):65-73. PubMed ID: 9117100
[TBL] [Abstract][Full Text] [Related]
20. Characterization of calcineurin from Hymenolepis microstoma and H. diminuta and its interaction with cyclosporin A.
Roberts HC; Sternberg JM; Chappell LH
Parasitology; 1997 Mar; 114 ( Pt 3)():279-83. PubMed ID: 9075347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
